» Articles » PMID: 39660027

Burden of Hospitalization for Coccidioidal Meningitis: An Analysis of the National Inpatient Sample, 2019-2021

Overview
Date 2024 Dec 11
PMID 39660027
Authors
Affiliations
Soon will be listed here.
Abstract

Coccidioidal meningitis (CM) requires lifelong aggressive management, often necessitating hospitalization. In the National Inpatient Sample (2019-2021), CM hospitalizations (N = 2305) were associated with frequent CM-related procedures (63.6% [95% confidence interval {CI}, 59.3%-67.6%]), long stays (mean, 13.0 days [95% CI, 11.3-14.6 days]), substantial costs per stay (mean, $48 155 [95% CI, $42 382-$53 929]), and a 7.6% (95% CI, 5.6%-10.3%) mortality incidence. CM inflicts a substantial burden on hospital resources.

Citing Articles

The Burden of Hospital Illness Associated with Disseminated Versus Isolated Pulmonary Coccidioidomycosis in the United States.

Coleman C, Bylyku J, Latifi A, Lovelace B, Shan R, Miriyapalli L J Fungi (Basel). 2025; 11(2).

PMID: 39997455 PMC: 11855934. DOI: 10.3390/jof11020161.

References
1.
Chu J, Feudtner C, Heydon K, Walsh T, Zaoutis T . Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis. 2006; 42(6):822-5. DOI: 10.1086/500405. View

2.
Luo R, Greenberg A, Stone C . Hospitalized burden and outcomes of coccidioidomycosis: A nationwide analysis, 2005-2012. Med Mycol. 2016; 55(4):368-374. PMC: 5896874. DOI: 10.1093/mmy/myw087. View

3.
Crum N . Coccidioidomycosis: A Contemporary Review. Infect Dis Ther. 2022; 11(2):713-742. PMC: 8887663. DOI: 10.1007/s40121-022-00606-y. View

4.
Galgiani J, Ampel N, Blair J, Catanzaro A, Geertsma F, Hoover S . Executive Summary: 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis. Clin Infect Dis. 2016; 63(6):717-22. DOI: 10.1093/cid/ciw538. View

5.
Sivasubramanian G, Kadakia S, Kim J, Pervaiz S, Yan Y, Libke R . Challenges in the Long-term Management of Patients With Coccidioidal Meningitis: A Retrospective Analysis of Treatment and Outcomes. Open Forum Infect Dis. 2023; 10(6):ofad243. PMC: 10270562. DOI: 10.1093/ofid/ofad243. View